These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27825427)

  • 1. Guest Editorial-Prostate Cancer.
    Bouchelouche K
    Semin Nucl Med; 2016 Nov; 46(6):482-483. PubMed ID: 27825427
    [No Abstract]   [Full Text] [Related]  

  • 2. Oligometastatic Prostate Cancer: Molecular Imaging and Clinical Management Implications in the Era of Precision Oncology.
    Jadvar H
    J Nucl Med; 2018 Sep; 59(9):1338-1339. PubMed ID: 30030344
    [No Abstract]   [Full Text] [Related]  

  • 3. [Metastatic cancer of the prostate: course, diagnosis and therapeutic management].
    Wisard M; Gabellon S
    Rev Med Suisse Romande; 1995 Mar; 115(3):241-7. PubMed ID: 7777765
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiologic seminar CLXVIII: carcinoma of the prostate--stage C.
    Sullivan BL
    J Miss State Med Assoc; 1977 Mar; 18(3):64-5. PubMed ID: 859176
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of functional imaging in prostate cancer: a clinical point of view.
    Nicolotti DG; Finessi M; Guarneri A; Pilati E; Giunta F; Deandreis D
    Q J Nucl Med Mol Imaging; 2019 Mar; 63(1):1-6. PubMed ID: 30644307
    [No Abstract]   [Full Text] [Related]  

  • 6. [3. Diagnostic Imaging for Prostate Cancer].
    Yoshida R; Yoshizako T; Kitagaki H
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2017; 73(6):477-485. PubMed ID: 28637962
    [No Abstract]   [Full Text] [Related]  

  • 7. Imaging of local recurrence in prostate cancer.
    McCammack KC; Raman SS; Margolis DJ
    Future Oncol; 2016 Nov; 12(21):2401-2415. PubMed ID: 27306275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer imaging: what surgeons, radiation oncologists, and medical oncologists want to know.
    Tabatabaei S; Saylor PJ; Coen J; Dahl DM
    AJR Am J Roentgenol; 2011 Jun; 196(6):1263-6. PubMed ID: 21606287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How could imaging reduce therapy-associated morbidity in rhabdomyosarcoma of the bladder or prostate?
    Kuru TH; Roethke M; Fenchel M; Hadaschik BA
    Future Oncol; 2013 Dec; 9(12):1797-800. PubMed ID: 24143879
    [No Abstract]   [Full Text] [Related]  

  • 10. Pretreatment staging of clinically localized prostate cancer. American College of Radiology. ACR Appropriateness Criteria.
    Amis ES; Bigongiari LR; Bluth EI; Bush WH; Choyke PL; Fritzsche P; Holder L; Newhouse JH; Sandler CM; Segal AJ; Resnick MI; Rutsky EA
    Radiology; 2000 Jun; 215 Suppl():703-8. PubMed ID: 11037488
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeted PET imaging for prostate-specific membrane antigen in prostate cancer.
    Hope TA; Aggarwal RR; Westphalen AC; Cooperberg MR; Greene KL
    Future Oncol; 2016 Nov; 12(21):2393-2396. PubMed ID: 27453303
    [No Abstract]   [Full Text] [Related]  

  • 12. The Promise of Metastasis-Directed Therapy for Oligometastatic Prostate Cancer: Going Beneath the Surface with Molecular Imaging.
    Sutera P; Phillips RM; Deek M; Ozyigit G; Onal C; Tran PT
    J Nucl Med; 2022 Mar; 63(3):339-341. PubMed ID: 35058322
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial: potential clinical use of exploiting metastasis suppressor genes to regulate prostatic cancer.
    Hendrix MJ
    J Urol; 2003 Mar; 169(3):1134. PubMed ID: 12576867
    [No Abstract]   [Full Text] [Related]  

  • 14. The revolution of prostate cancer management with nuclear medicine: transforming diagnosis and treatment.
    Evangelista L; Ceci F
    Q J Nucl Med Mol Imaging; 2024 Jun; 68(2):93-94. PubMed ID: 38860272
    [No Abstract]   [Full Text] [Related]  

  • 15. Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment.
    Jadvar H; Ballas LK; Choyke PL; Fanti S; Gulley JL; Herrmann K; Hope TA; Klitzke AK; Oldan JD; Pomper MG; Rowe SP; Subramaniam RM; Taneja SS; Vargas HA; Ahuja S
    J Nucl Med; 2020 Apr; 61(4):552-562. PubMed ID: 32238495
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostate cancer diagnosis and management.
    Frydenberg M; Stricker PD; Kaye KW
    Lancet; 1997 Jun; 349(9066):1681-7. PubMed ID: 9186395
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical Applications of Molecular Imaging in the Management of Prostate Cancer.
    Gorin MA; Rowe SP; Denmeade SR
    PET Clin; 2017 Apr; 12(2):185-192. PubMed ID: 28267452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New clinical imaging modalities in prostate cancer.
    Ross R; Harisinghani M
    Hematol Oncol Clin North Am; 2006 Aug; 20(4):811-30. PubMed ID: 16861116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1992 staging system for prostate cancer.
    Montie JE
    Semin Urol; 1993 Feb; 11(1):10-3. PubMed ID: 7682002
    [No Abstract]   [Full Text] [Related]  

  • 20. [Imaging in metastatic prostate cancer].
    Ohlmann CH
    Urologe A; 2021 Jul; 60(7):950-951. PubMed ID: 33760926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.